drugset / Trial / NCT06304961
A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
The study will assess the relative bioavailability between two dosage forms of tozorakimab (test dosage form and reference dosage form) and to assess the pharmacokinetic (PK) profiles of both dosage forms.
Timeline
- Start
- 2024-04-08
- Primary completion
- 2024-09-09
- Completion
- 2024-09-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tozorakimab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.